VULLO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.113
EU - Europa 9.590
AS - Asia 7.958
SA - Sud America 1.810
AF - Africa 313
OC - Oceania 172
Continente sconosciuto - Info sul continente non disponibili 5
Totale 46.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.943
RU - Federazione Russa 3.412
PL - Polonia 2.301
SG - Singapore 2.243
CN - Cina 1.630
BR - Brasile 1.495
HK - Hong Kong 1.276
VN - Vietnam 1.096
IE - Irlanda 987
IT - Italia 850
KR - Corea 787
SE - Svezia 620
FI - Finlandia 354
FR - Francia 319
IN - India 276
DE - Germania 265
GB - Regno Unito 198
AU - Australia 168
TR - Turchia 134
AR - Argentina 119
CI - Costa d'Avorio 101
BD - Bangladesh 88
ES - Italia 87
UA - Ucraina 83
ID - Indonesia 77
CA - Canada 74
NG - Nigeria 64
IQ - Iraq 58
JP - Giappone 54
MX - Messico 53
EC - Ecuador 52
ZA - Sudafrica 36
PY - Paraguay 35
PK - Pakistan 34
CO - Colombia 32
JO - Giordania 32
MA - Marocco 30
NL - Olanda 26
VE - Venezuela 25
SA - Arabia Saudita 21
EG - Egitto 20
CL - Cile 19
TN - Tunisia 18
UZ - Uzbekistan 17
BE - Belgio 16
PH - Filippine 16
TW - Taiwan 16
PE - Perù 15
KE - Kenya 11
UY - Uruguay 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
LT - Lituania 9
NP - Nepal 9
CH - Svizzera 8
PS - Palestinian Territory 8
BG - Bulgaria 7
BO - Bolivia 7
IL - Israele 7
OM - Oman 7
SV - El Salvador 7
AT - Austria 6
JM - Giamaica 6
AL - Albania 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
PA - Panama 5
PT - Portogallo 5
QA - Qatar 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
IR - Iran 4
KG - Kirghizistan 4
LB - Libano 4
MU - Mauritius 4
MY - Malesia 4
NI - Nicaragua 4
AM - Armenia 3
BJ - Benin 3
BY - Bielorussia 3
EU - Europa 3
GE - Georgia 3
MD - Moldavia 3
MK - Macedonia 3
MN - Mongolia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
Totale 46.936
Salva come PNG Salva come JPEG
Città #
Fairfield 4.261
Ashburn 3.385
Santa Clara 3.323
Warsaw 2.300
Woodbridge 2.124
Seattle 1.835
Cambridge 1.658
Singapore 1.577
Houston 1.563
Wilmington 1.281
Hong Kong 996
Dublin 982
Seoul 781
Chandler 698
Ann Arbor 563
Lawrence 508
Altamura 504
San Jose 448
Princeton 423
Ho Chi Minh City 358
The Dalles 330
Beijing 294
Lauterbourg 277
Hefei 271
Hanoi 230
Los Angeles 184
Boston 180
Jacksonville 174
Medford 173
Melbourne 166
Boardman 158
Buffalo 154
San Diego 152
Moscow 150
Mumbai 149
Clifton 127
Florence 127
Dallas 123
São Paulo 114
Council Bluffs 105
Abidjan 101
Dong Ket 78
New York 75
Redondo Beach 75
Barcelona 72
Falls Church 72
Helsinki 63
Abuja 60
Norwalk 56
Izmir 54
Kent 50
Munich 49
Da Nang 46
Shanghai 46
Rio de Janeiro 44
Jakarta 42
Tokyo 41
Belo Horizonte 39
Guangzhou 39
Wuhan 38
Phoenix 36
Toronto 36
Brasília 35
Chicago 35
Frankfurt am Main 34
Hillsboro 33
London 33
Haiphong 31
Orem 31
Andover 30
Paris 26
Rome 23
Brooklyn 22
Düsseldorf 22
Baghdad 21
Campinas 21
Yubileyny 19
Curitiba 18
Hải Dương 18
Ninh Bình 18
Quito 18
Ribeirão Preto 18
Asunción 17
Bengaluru 17
Dearborn 17
Dhaka 17
Tianjin 17
Brussels 16
Biên Hòa 15
Guarulhos 15
Guayaquil 15
Porto Alegre 15
Salvador 15
Turku 15
San Francisco 14
São José dos Campos 14
Tashkent 14
Thái Nguyên 14
Atlanta 13
Bắc Ninh 13
Totale 35.197
Salva come PNG Salva come JPEG
Nome #
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis 347
Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity. 309
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis 298
Anion inhibition studies of a beta carbonic anhydrase from the malaria mosquito Anopheles gambiae 295
Carbonic anhydrases activation with 3-amino-1H-1,2,4-triazole-1-carboxamides: Discovery of subnanomolar isoform II activators 295
Natural product polyamines that inhibit human carbonic anhydrases 292
Sulfonamide inhibition profile of the γ-carbonic anhydrase identified in the genome of the pathogenic bacterium Burkholderia pseudomallei the etiological agent responsible of melioidosis 291
Ascaris lumbricoides β carbonic anhydrase: A potential target enzyme for treatment of ascariasis 276
Ferrier sulfamidoglycosylation of glycals catalyzed by nitrosonium tetrafluoroborate: Towards new carbonic anhydrase glycoinhibitors 273
Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect 271
Carbonic Anhydrase Activators: Gold Nanoparticles Coated with Derivatized Histamine, Histidine, and Carnosine Show Enhanced Activatory Effects on Several Mammalian Isoforms. 269
Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae 268
Mapping Selective Inhibition of the Cancer-Related Carbonic Anhydrase IX Using Structure-Activity Relationships of Glucosyl-Based Sulfamates 267
Natural product coumarins that inhibit human carbonic anhydrases. 262
Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. 261
7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits α-carbonic anhydrases without hydrolysis of the lactam ring. 261
S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. 251
Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase 246
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 244
Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII 228
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? 227
Biochemical characterization of the δ-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA 217
PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with 68Ga-Labeled Benzenesulfonamides 216
Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. 209
A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome 200
Activation Profile Analysis of CruCA4, an α-Carbonic Anhydrase Involved in Skeleton Formation of the Mediterranean Red Coral, Corallium rubrum 199
In vitro inhibition of Mycobacterium tuberculosis β-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos 197
Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis 195
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors 191
Potent and Selective Carboxylic Acid Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII 191
Analysis of a shortened form of human carbonic anhydrase VII expressed in vitro compared to the full-length enzyme. 189
A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents 188
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense. 187
Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics 187
Design and validation of FRESH, a drug discovery paradigm resting on robust chemical synthesis 185
Plasmonic Particles that Hit Hypoxic Cells 184
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 180
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 179
Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei 178
Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum 178
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. 177
4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII 177
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis 176
Biochemical characterization of the native α-carbonic anhydrase purified from the mantle of the Mediterranean mussel, Mytilus galloprovincialis 175
Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action 175
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. 174
Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. 174
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 174
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. 173
A new procedure for the cloning, expression and purification of the β-carbonic anhydrase from the pathogenic yeast Malassezia globosa, an anti-dandruff drug target 173
Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. 172
Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates. 172
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition. 172
Active components of essential oils as anti-obesity potential drugs investigated by in silico techniques 172
An anion and small molecule inhibition study of the β-carbonic anhydrase from Staphylococcus aureus 172
Carbonic anhydrase inhibitors: glycosylsulfanilamides act as subnanomolar inhibitors of the human secreted isoform VI. 171
3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors. 171
Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety. 169
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. 169
Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). 169
In Vivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 169
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis. 168
A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth. 168
5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations 168
Pyridinium derivatives of histamine are potent activators of cytosolic carbonic anhydrase isoforms I, II and VII. 166
A new way of synthesizing heterocyclic primary sulfonamide probes for carbonic anhydrase 165
Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions. 165
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases. 165
Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. 164
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 164
New β-arylchalcogeno amines with procognitive properties targeting Carbonic Anhydrases and Monoamine Oxidases 164
Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors. 163
Metallocene-based inhibitors of cancer-associated carbonic anhydrase enzymes IX and XII. 163
Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions. 163
Poly(amidoamine) dendrimers with carbonic anhydrase inhibitory activity and antiglaucoma action 163
Cloning, characterization and anion inhibition studies of a γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea 163
Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. 162
Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 161
Poly(amidoamine) dendrimers show carbonic anhydrase inhibitory activity against α-, β-, γ- and η-class enzymes 161
A Series of Thiadiazolyl-Benzenesulfonamides Incorporating an Aromatic Tail as Isoform-Selective, Potent Carbonic Anhydrase II/XII Inhibitors 160
Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. 160
Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. 160
Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines. 160
Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold. 160
Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. 159
Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides. 159
Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. 158
The first activation study of a bacterial carbonic anhydrase (CA). The thermostable α-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines. 158
Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV. 157
Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease 157
Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV. 157
Monothiocarbamates Strongly Inhibit Carbonic Anhydrases in Vitro and Possess Intraocular Pressure Lowering Activity in an Animal Model of Glaucoma 157
Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. 156
Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates 156
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis 156
Reconstitution of carbonic anhydrase activity of the cell-surface-binding protein of vaccinia virus. 155
Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions. 155
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. 155
Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum 155
Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II. 155
Totale 19.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021498 0 0 0 0 0 0 0 0 0 0 252 246
2021/20222.025 90 215 276 52 50 98 110 171 70 95 208 590
2022/20234.119 610 1.103 82 213 285 745 449 146 283 49 101 53
2023/20241.198 79 165 334 57 72 145 38 181 24 40 35 28
2024/20259.793 394 1.108 704 1.288 3.135 908 142 494 708 312 277 323
2025/202611.787 973 1.852 1.171 1.502 1.261 640 1.598 842 866 753 329 0
Totale 47.207